Semaglutide and similar GLP-1 drugs are poised to become frontline treatments for a severe form of liver disease.

An international study reveals that the drug can reverse liver damage in patients. An international study led by researchers ...

Experts say semaglutide may be a much-needed treatment option for a liver disease with few current therapies. Ozempic is effective in treating a severe form of liver disease that affects millions ...

Related FDA warns of fake Ozempic Type 2 diabetes injection ... Currently, there is only one U.S. government-approved treatment available for fatty liver disease, Rezdiffra (resmetirom ...

Semaglutide, sold under brand names like Ozempic, Rybelsus ... process could transform how we approach advanced liver disease treatment. Participants receiving semaglutide experienced an average ...

A new study brings into focus the relationship between diabetic GLP-1 users and the elevated risk of age-related eye disease.

a serious form of fatty liver disease. The use of semaglutide, a medication from the class of GLP-1 receptor agonists, has become increasingly popular. The brands Rybelsus and Ozempic are ...

A recommended 150 minutes per week at moderate intensity can help reduce liver inflammation and rid the organ of fat.

The Wall Street Journal reports on the expected FDA approval of lenacapavir and what it might mean for Gilead's future in the market. Other coverage of science and research-related news is on a ...

Scientists are continuing to find evidence that GLP-1 medications can temper cravings for alcohol and other drugs.

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...